The Pill for Everything: Why Off-Label Gabapentin Prescriptions Are Soaring
Gabapentin, an anti-seizure drug, has become the fifth-most prescribed medication in the U.S. largely for unapproved uses like pain and insomnia. Doctors increasingly prescribe it because it has fewer side effects than older alternatives, but experts warn the trend masks inadequate diagnosis and carries risks including dependency, cognitive decline, and dangerous drug interactions—especially in older adults.
- Gabapentin prescriptions have skyrocketed for off-label uses (pain, insomnia, hot flashes) that the FDA never approved, driven by its low cost, favorable side effect profile compared to older drugs, and genuine gaps in treatment options.
- High doses and inadequate monitoring create serious risks: dizziness and falls in older patients, kidney function decline without dose adjustment, and potential withdrawal symptoms (insomnia, anxiety, seizures) after prolonged use.
- The drug often becomes a long-term band-aid masking underlying conditions that need targeted treatment—one patient took gabapentin for three years before an MRI revealed severe arthritis and disc problems treatable with steroid injections.
Gabapentin, an anti-seizure drug, has become the fifth-most prescribed medication in America—not because seizures are increasing, but because doctors are writing millions of prescriptions for conditions the FDA never approved it for, like back pain, insomnia, and hot flashes. The drug's popularity exploded partly because of aggressive off-label marketing by Parke-Davis in the late 1990s, but also because it causes fewer side effects than older alternatives like tricyclic antidepressants, costs relatively little, and actually does help some patients with nerve pain and other conditions. The problem is that this "permissive environment for off-label use" often happens without adequate monitoring. One Wisconsin man took gabapentin for three years at doses up to 900 mg nightly for severe leg pain that disrupted his sleep and walking—only to discover through an MRI that he had severe arthritis and bulging discs that could have been treated with targeted steroid injections much earlier.
The evidence for gabapentin's effectiveness is mixed and sometimes disappointing. Research shows it can reduce diabetic nerve pain and chronic cough, but pregabalin works significantly better for nerve pain. For hot flashes, a 2020 meta-analysis found it helps some women avoid hormone replacement therapy. For alcohol use disorder, it's unclear whether it actually works. The real issue is that doctors often skip non-drug treatments like physical therapy or proper diagnosis before prescribing it, and some patients end up on gabapentin as a band-aid solution when they need actual investigation into what's causing their symptoms.
The risks are substantial and often overlooked. Gabapentin causes dizziness and falls in older patients, sometimes forcing them to stop driving. Doctors sometimes use it to treat side effects from other medications, creating a cascade of unnecessary pills instead of fixing the root problem. Since the kidneys break down gabapentin, kidney function decline with age means older adults accumulate the drug in their systems—yet prescribers often don't adjust doses accordingly. Even more concerning, patients on high doses for months can experience withdrawal symptoms like insomnia, anxiety, and rarely seizures if they stop abruptly. Withdrawal can last up to 10 days, which is why tapering is necessary, though some doctors don't inform patients of this risk.